Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
about
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activitiesMolecular cloning and functional characterization of the pig homologue of integrin-associated protein (IAP/CD47).Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.LIMLE, a new molecule over-expressed following activation, is involved in the stimulatory properties of dendritic cells.An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in miceProtection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates.Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivoHuman decay-accelerating factor and CEACAM receptor-mediated internalization and intracellular lifestyle of Afa/Dr diffusely adhering Escherichia coli in epithelial cells.Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope.Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicityProtection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.Molecular and functional analysis of mouse decay accelerating factor (CD55)Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding.An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy.A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice.Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo.Loxosceles spider venom induces metalloproteinase mediated cleavage of MCP/CD46 and MHCI and induces protection against C-mediated lysis.
P2860
Q28570196-C75A2343-E8CB-42EE-ACD8-C37332033F45Q31100437-B12249C8-633B-40F4-82F8-A313915BE87EQ33936717-D9069170-9B5C-4FC9-9C71-58778918652CQ35140539-3D40E958-27A6-4ED8-AD78-86ED3B8A4989Q36306007-3AA8353F-15A7-455F-83F5-955BCFECF251Q36438512-D5DDBBD7-15DA-4172-9467-B7A25B536EABQ36496450-F06CE5B5-1008-4470-A8B6-49B6C0DE6C2EQ36563619-D95A49E1-E706-456B-ADB6-CC7C6AF91D70Q36947184-DBE82C45-2095-4C9D-B684-6DD2506965FCQ37033128-0589E9C7-1AEB-493F-95E9-AA580BF262A8Q38341233-1983ACA3-F05B-492C-945E-B382774ECBAEQ39735226-4EE033E3-9445-4E01-AE59-9A50D3E3AE99Q40975372-42DBF484-EC73-45DE-8326-D8947FBEA6CEQ41808735-8C17AB05-420A-477A-AEDF-44156E3CB45CQ41810495-5B9DE3F1-B0CC-431E-A058-2B9CA0AB45CEQ42625961-FA31FFAF-5C92-4CE2-A2C1-E1C93263542CQ47669801-24392F35-5E0A-449B-A3A8-E908DC25ED70Q53666820-6A229DE5-D660-498D-9C75-2E19CF8B94F6Q53959205-791FAFBD-143A-41CB-BB4F-37CDD2793703
P2860
Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Protection of rat endothelial ...... /or decay-accelerating factor.
@en
Protection of rat endothelial ...... /or decay-accelerating factor.
@nl
type
label
Protection of rat endothelial ...... /or decay-accelerating factor.
@en
Protection of rat endothelial ...... /or decay-accelerating factor.
@nl
prefLabel
Protection of rat endothelial ...... /or decay-accelerating factor.
@en
Protection of rat endothelial ...... /or decay-accelerating factor.
@nl
P2093
P1433
P1476
Protection of rat endothelial ...... d/or decay-accelerating factor
@en
P2093
Blanchard D
Le Mauff B
Navenot JM
Soulillou JP
P304
P577
1994-12-01T00:00:00Z